9NQ9 image
Deposition Date 2025-03-12
Release Date 2025-11-19
Last Version Date 2025-11-19
Entry Detail
PDB ID:
9NQ9
Title:
Magnesium ions-bound closed-state cryo-EM structure of human TRPV6 in cNW11 nanodiscs
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.97 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Structures with similar UniProt ID
Protein Blast
Polymer Type:polypeptide(L)
Molecule:Transient receptor potential cation channel subfamily V member 6
Gene (Uniprot):TRPV6
Chain IDs:A, B, C, D
Chain Length:612
Number of Molecules:4
Biological Source:Homo sapiens
Primary Citation
The locking mechanism of human TRPV6 inhibition by intracellular magnesium.
Nat Commun 16 9826 9826 (2025)
PMID: 41198662 DOI: 10.1038/s41467-025-65919-1

Abstact

TRPV6 is a member of the vanilloid subfamily of transient receptor potential channels, which serves as the master regulator of Ca2+ homeostasis. TRPV6 functions as a constitutively active Ca2+ channel, and emerging evidence indicates that its overactivity underpins the progression of several human diseases, including cancer. Hence, there is a pressing need to identify TRPV6 inhibitors in conjunction with a deep mechanistic understanding of their effects on the channel activity. Here we combine cryo-electron microscopy, mutagenesis, electrophysiology and molecular dynamics modeling to decipher the molecular mechanism of TRPV6 inhibition by intracellular Mg2+. Mg2+ appears to bind to four, one per subunit, sites around the intracellular entrance to the TRPV6 channel pore, contributed by the negatively charged residues, D489 in the transmembrane helix S5 and D580 in S6. When bound to the D489-D580 site, Mg2+ prevents the α-to-π transition in the middle of S6 that accompanies channel opening, thus maintaining S6 entirely α-helical, locking the channel in the closed state and inhibiting TRPV6-mediated currents. Further exploration of this inhibitory mechanism may help to develop future strategies for the treatment of TRPV6-associated diseases.

Legend

Protein

Chemical

Disease

Primary Citation of related structures
Feedback Form
Name
Email
Institute
Feedback